The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293

Asrar Qureshi’s blog discusses the exit of multinational pharmaceutical companies from Pakistan and the country’s potential to attract them back. Highlighting necessary reforms in pricing, regulation, and clinical research, it stresses a long-term vision for the pharmaceutical sector as vital for economic growth and public health security. Collaboration between domestic and multinational firms is essential for success.
Share
View Post

Basic Mistakes Job Seekers Make – Asrar Qureshi’s Blog Post 1052

Asrar Qureshi’s blog highlights the evolving landscape of job seeking, contrasting older and younger generations’ views on career loyalty. It outlines common mistakes candidates make, including unclear job-switching purpose, lack of research, generic applications, and poor interview preparation. Emphasizing clarity, customization, and professionalism boosts job-seeking success.
Share
View Post

New Drug Modalities – Asrar Qureshi’s Blog Post 1047

Asrar Qureshi’s blog discusses the Boston Consulting Group’s second annual report on the growth of new drug modalities. It highlights advancements in antibodies, recombinant products, cell therapies, gene therapies, and mRNA applications, emphasizing their implications for biopharma companies and patient care. The future of these modalities depends on their unique benefits and market speed.
Share